Metabolic TME Remodeling Services for Improved CAR-T Persistence

Online Inquiry

Background Service Service Packages Workflow Highlights FAQs Contact

While CAR-T therapy holds great promise, its efficacy is frequently compromised by T cell exhaustion, limited infiltration into solid tumors, and a metabolically suppressive tumor microenvironment. Creative Biolabs' Metabolic TME Remodeling service is designed to overcome these obstacles, thereby bolstering CAR-T persistence and overall therapeutic outcomes. We offer an integrated platform that combines nutrient reprogramming, enzymatic modulation, and precision LNP-based metabolic delivery. This strategy effectively restores intratumoral fitness, endowing your CAR-T products with enhanced durability and clinical promise.

Introduction

Metabolic TME remodeling involves the deliberate reshaping of the tumor microenvironment, modulating nutrient supply, metabolic waste products, and immunosuppressive cell populations, to establish a more supportive setting for adoptive T cell therapy. Such remodeling is essential for sustaining CAR‑T persistence, as it directly counteracts the metabolic stressors that lead to T cell exhaustion, thus promoting durable effector function and enhancing long‑term therapeutic efficacy.

Fig.1 The role of metabolism in T cell differentiation. (OA Literature) Fig.1 Metabolic pathways shaping T cell differentiation.¹

Metabolic TME Remodeling for Improved CAR-T Persistence at Creative Biolabs

Creative Biolabs offers a dedicated suite of solutions engineered to bridge the divide between persistence and potency. Rather than focusing solely on CAR-T engineering, our approach reshapes the metabolic interplay between therapeutic cells and the suppressive tumor microenvironment. Through targeted neutralization of inhibitory metabolites and enhancement of oxidative capacity, we enable your candidates to endure where conventional strategies fall short.

Service Packages

CAR-T Acidification Reversal via Enzyme-Loaded Vesicles

This platform addresses the immunosuppressive acidic tumor microenvironment, which impairs CAR-T cell metabolism and effector function. By utilizing enzyme-loaded vesicles that locally neutralize extracellular protons, this approach restores a physiological pH at the tumor site, thereby reversing T cell metabolic acidosis and preserving cytotoxic activity. This technology is particularly suited for solid tumors characterized by profound lactic acid accumulation, enabling sustained CAR-T cell fitness and enhanced tumor clearance.

Learn More →

Oxygenation Support & Hypoxia Alleviation for CAR-T Revitalization

Chronic hypoxia within the tumor microenvironment drives CAR-T cell exhaustion and limits their proliferative capacity. This strategy employs localized oxygen delivery systems to relieve hypoxic stress, creating a permissive niche that supports T cell oxidative metabolism and memory differentiation. Applications include combination with CAR-T therapy for poorly vascularized or necrotic tumors, where improved oxygen availability translates to enhanced persistence, reduced exhaustion, and more durable antitumor responses.

Learn More →

Targeted Nutrient Supplementation (L-Arginine) for CAR-T Metabolic Fuel

L-arginine is a critical nutrient for T cell survival, proliferation, and the formation of central memory subsets, yet its availability is frequently depleted in the tumor microenvironment. This approach delivers L-arginine in a targeted, sustained manner directly to the tumor site, selectively fueling CAR-T cells to maintain robust metabolic activity and long-term persistence. This modality is particularly valuable for enhancing the durability of CAR-T therapy in metabolically hostile tumors, supporting both immediate effector function and sustained immunological memory.

Learn More →

Our Service Process

Required Starting Materials:

Target-specific CAR-T or CAR-NK cell constructs.
Characterized tumor cell lines or patient-derived xenograft (PDX) samples.
Baseline metabolic profiles or previous in vivo persistence data (if available).

Key Steps:

Workflow of metabolic TME remodeling for improved CAR-T persistence at Creative Biolabs. (Creative Biolabs Original)

Final Deliverables:

A comprehensive Metabolic Fitness Report.
Validated Efficacy Data Sets.

Key Advantages

Alleviates Nutrient Competition: By targeting immunosuppressive myeloid cells and modulating tumor metabolism, this approach reduces the consumption of essential nutrients such as glucose, arginine, and glutamine, thereby preserving the metabolic fitness of CAR‑T cells.
Neutralizes Toxic Metabolites: Remodeling the TME with agents like MCT1 inhibitors or lactate‑consuming CAR‑T cells lowers the accumulation of lactate, adenosine, and ROS, which are otherwise detrimental to T‑cell function and persistence.
Enhances Intrinsic CAR‑T Cell Fitness: Genetic engineering that introduces constitutive co‑stimulation, knocks out metabolic checkpoints, or enforces mitochondrial biogenesis equips CAR‑T cells to withstand the metabolically hostile TME and maintain long‑term persistence.

FAQs

Q1: How does metabolic remodeling differ from standard CAR-T engineering?

A1: Conventional CAR-T engineering primarily focuses on enhancing tumor recognition and activation. In contrast, our approach centers on metabolic fitness, equipping T cells with optimized energy pathways that allow them to survive and function effectively within the nutrient-deprived, suppressive TME, thereby supporting long-term persistence.

Q2: Does metabolic remodeling increase the risk of over-activation?

A2: No. Rather than driving hyper-activation, our strategy emphasizes cellular resilience and metabolic adaptability. By improving the T cell's capacity to withstand environmental stress, this approach typically reduces the likelihood of excessive inflammatory responses, while preserving potent and sustained antitumor activity.

Why Choose Us?

We specialize in metabolic TME remodeling, an approach that goes beyond conventional CAR‑T engineering. By combining advanced cell programming with strategies to reshape the tumor microenvironment, we enable sustained T‑cell persistence, functional resilience, and durable antitumor activity where traditional platforms fall short.

How to contact us?

We invite inquiries from research groups and industry partners seeking to advance CAR‑T persistence through metabolic TME remodeling. Reach out to discuss collaboration, technology access, or tailored solutions, our team is ready to support your program from discovery to translation.

Reference

Frlic, Tjaša, and Mojca Pavlin. "Metabolic reprogramming of CAR T cells: a new frontier in cancer immunotherapy." Frontiers in immunology vol. 16 1688995. Distributed under Open Access License CC BY 4.0, without modification. https://doi.org/10.3389/fimmu.2025.1688995.

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.